Cargando…
Introduction to tobacco control supplement
Electronic cigarettes (e-cigarettes) have recently gained significant attention in the marketplace and in the media. However, limited information is available about the worldwide impact of e-cigarettes; most public health officials are calling for more data so they can more fully understand the pote...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995278/ https://www.ncbi.nlm.nih.gov/pubmed/24732156 http://dx.doi.org/10.1136/tobaccocontrol-2013-051504 |
_version_ | 1782312854687318016 |
---|---|
author | Chen, Ii-Lun Husten, Corinne G |
author_facet | Chen, Ii-Lun Husten, Corinne G |
author_sort | Chen, Ii-Lun |
collection | PubMed |
description | Electronic cigarettes (e-cigarettes) have recently gained significant attention in the marketplace and in the media. However, limited information is available about the worldwide impact of e-cigarettes; most public health officials are calling for more data so they can more fully understand the potential risks and benefits of e-cigarettes in order to inform regulatory action. In the USA, e-cigarettes that are marketed as tobacco products are not currently regulated by the Food and Drug Administration (FDA). However, having a continuum of nicotine-containing products that cross jurisdictional lines within the FDA in the future would create the potential (and the need) for a comprehensive nicotine strategy at the FDA. As part of developing the most appropriate approach to e-cigarette regulation, FDA Center for Tobacco Products scientists have been reviewing the available literature to determine the state of e-cigarette knowledge and have identified research areas that could be addressed. This supplement provides a summary of the current knowledge and research gaps pertaining to e-cigarettes with regards to product design, chemistry and toxicology of e-liquid and aerosol constituents, human factor-based risk factors, abuse liability, clinical pharmacology and human health effects, paediatric issues, and environmental issues. |
format | Online Article Text |
id | pubmed-3995278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-39952782014-04-25 Introduction to tobacco control supplement Chen, Ii-Lun Husten, Corinne G Tob Control Introduction Electronic cigarettes (e-cigarettes) have recently gained significant attention in the marketplace and in the media. However, limited information is available about the worldwide impact of e-cigarettes; most public health officials are calling for more data so they can more fully understand the potential risks and benefits of e-cigarettes in order to inform regulatory action. In the USA, e-cigarettes that are marketed as tobacco products are not currently regulated by the Food and Drug Administration (FDA). However, having a continuum of nicotine-containing products that cross jurisdictional lines within the FDA in the future would create the potential (and the need) for a comprehensive nicotine strategy at the FDA. As part of developing the most appropriate approach to e-cigarette regulation, FDA Center for Tobacco Products scientists have been reviewing the available literature to determine the state of e-cigarette knowledge and have identified research areas that could be addressed. This supplement provides a summary of the current knowledge and research gaps pertaining to e-cigarettes with regards to product design, chemistry and toxicology of e-liquid and aerosol constituents, human factor-based risk factors, abuse liability, clinical pharmacology and human health effects, paediatric issues, and environmental issues. BMJ Publishing Group 2014-05 /pmc/articles/PMC3995278/ /pubmed/24732156 http://dx.doi.org/10.1136/tobaccocontrol-2013-051504 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Introduction Chen, Ii-Lun Husten, Corinne G Introduction to tobacco control supplement |
title | Introduction to tobacco control supplement |
title_full | Introduction to tobacco control supplement |
title_fullStr | Introduction to tobacco control supplement |
title_full_unstemmed | Introduction to tobacco control supplement |
title_short | Introduction to tobacco control supplement |
title_sort | introduction to tobacco control supplement |
topic | Introduction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995278/ https://www.ncbi.nlm.nih.gov/pubmed/24732156 http://dx.doi.org/10.1136/tobaccocontrol-2013-051504 |
work_keys_str_mv | AT cheniilun introductiontotobaccocontrolsupplement AT hustencorinneg introductiontotobaccocontrolsupplement |